Retour
Résumé des données probantes

Qu'est-ce qu'un Résumé des données probantes?

Les messages clés des recherches scientifiques sur lesquels on peut agir

J'ai compris, masquez ceci
  • Cote:

Not enough evidence to show that over-the-counter supplements prevent cognitive decline in healthy adults or people with mild cognitive impairment

Butler M, Nelson VA, Davila H, et al. Les interventions ayant recours aux suppléments en vente libre pour prévenir le déclin cognitif, les troubles cognitifs légers et la démence clinique de type Alzheimer: une revue systématique. Ann Intern Med. 2018;168:52-62.

Review questions

In adults without cognitive impairment, do supplements that don’t need a prescription (over-the-counter [OTC] supplements) prevent cognitive decline or dementia? Do OTC supplements work in adults with mild cognitive impairment?

Background

Cognitive function includes abilities such as thinking, remembering, using language, and making decisions. As we get older, our cognitive functions may decline. Mild cognitive impairment includes cognitive changes that are noticeable but usually don’t have much effect on daily living. Dementia is cognitive impairment that is serious enough to interfere with daily living.

Many people use OTC supplements to prevent or delay cognitive decline. However, we don’t know which supplements, if any, reduce risk for cognitive decline.

How the review was done

The researchers did a systematic review of studies available up to July 2017. They analyzed 38 studies; most were randomized controlled trials.

The key features of the studies were:

  • people had normal cognition or mild cognitive impairment;
  • people with dementia were excluded;
  • OTC supplements included omega-3 fatty acids, soy, ginkgo biloba, B vitamins, vitamin E, vitamin D plus calcium, vitamin C, beta-carotene, and multivitamins;
  • OTC supplements were mainly compared with placebo; some OTC supplements were compared with another supplement;
  • people were followed up for at least 6 months; and
  • about 33% of studies were funded by industry.

What the researchers found

Most of the evidence was of low strength (confidence in results was limited) or insufficient to reach any conclusions. Some evidence was of moderate strength (moderate confidence in results).

Results in adults with normal cognition

Compared with placebo (also see Table below):

  • omega-3 fatty acids, gingko biloba, vitamin E, vitamin D plus calcium, and multivitamins did not reduce risk for dementia (low-strength evidence);
  • folic acid plus vitamin B12 improved memory (low-strength evidence);
  • vitamin E and B vitamins did not improve cognitive function (moderate-strength evidence); and
  • omega-3 fatty acids, soy, gingko biloba, folate plus vitamins B6 and B12, vitamin D plus calcium, vitamin C, beta-carotene, and multivitamins did not improve cognitive function (low-strength evidence).

Compared with other supplements:

  • omega-3 fatty acid supplements, with or without B vitamins, did not improve global cognitive test results or memory compared with B vitamins alone at 4 years in 1 study with 884 people (low-strength evidence).

Results in adults with mild cognitive impairment

Compared with placebo:

  • vitamin E did not reduce risk for dementia at 3 years in 1 study with 516 people (low-strength evidence); and
  • evidence was insufficient to evaluate other supplements (6 studies).

Conclusion

In people with normal cognition or mild cognitive impairment, there isn’t enough evidence to show that any over-the-counter supplements prevent cognitive decline.

Over-the-counter supplements vs placebo in adults with normal cognition*

Supplements

Number of studies and people

Effect of supplements

Strength of evidence†

Omega-3 fatty acids

7 studies (21,027 people)

No benefits for preventing dementia at 6.2 years (1 study) or for overall cognitive tests, memory, executive function‡, attention, or processing speed at 2 to 6 years (1 to 5 studies)

Low

Soy

5 studies (829 people)

No benefits for memory, executive function‡, attention, or processing speed at 2.5 years

Low

Gingko biloba

3 studies (5,559 people)

No benefits for preventing dementia (3 studies) or for overall cognitive test results, memory, executive function‡, attention, or processing speed (1 study) at 6 years

Low

B vitamins (folic acid + vitamin B12)

2 studies (3,819 people)

Improved memory at 2 years

Low

 

 

No benefits for executive function‡, attention, or processing speed at 2 years

Moderate

B vitamins (folate + vitamins B6 and B12)

2 studies (1,524 people)

No benefits for overall cognitive test results or memory at 3.3 to 4 years

Low

Vitamin E

3 studies (12,830 people)

No benefits for preventing dementia at 10 years (1 study)

Low

 

 

No benefits for overall cognitive test results or memory at 4 years (2 studies)

Moderate

Multivitamins

4 studies (27,613 people)

No benefits for preventing dementia or mild cognitive impairment at 5 years (1 study) or for overall cognitive test results (1 study) or memory, executive function‡, attention, or processing speed (2 studies) at 1 year or an undefined time

Low

Vitamin D + calcium

1 study (4,143 people)

No benefits for preventing dementia or mild cognitive impairment or for memory, executive function‡, attention, or processing speed at 7 years

Low

Vitamin C

1 study (2,471 people)

No benefits for overall cognitive test results or memory at 4 years

Low

Beta-carotene

1 study (2,471 people)

No benefits for overall cognitive test results or memory at 4 years

Low

*The Table doesn’t include outcomes with insufficient evidence to evaluate supplement effects.

†Ratings: insufficient evidence or low- (limited confidence in results), moderate-, or high- (very confident in results) strength evidence.

‡Executive function includes activities such as problem-solving, judgment, and decision-making.




Glossaire

Cognitive function
Mental processes, including thinking, learning and remembering.
Cognitive impairment
Trouble remembering, learning new things, concentrating, or making decisions that affect everyday life.
Placebo
A harmless, inactive, and simulated treatment.
Randomized controlled trials
Studies where people are assigned to one of the treatments purely by chance.
Systematic review
A comprehensive evaluation of the available research evidence on a particular topic.

Ressources Web connexes

  • La maladie d'Alzheimer: est-ce que les produits à base de Ginkgo biloba peuvent aider?

    Informed Health Online
    Les suppléments de Gingko biloba (240 mg par jour) peuvent aider à réduire les symptômes de la maladie d'Alzheimer et vous permettre de mieux effectuer vos tâches quotidiennes. Soyez conscient que le Gingko biloba peut interagir avec d'autres médicaments, alors parlez-en à votre médecin avant de prendre des suppléments. Cette ressource est disponible en anglais.
  • Inquiet par la démence? Voici 5 façons de réduire vos risques

    HealthLine
    La démence affecte des millions de personnes dans le monde et il n’existe actuellement aucun traitement. Il existe plusieurs moyens de réduire vos risques. Ayez une alimentation équilibrée, faites de l'exercice, restez engagés socialement et limitez votre consommation d'alcool et de tabac. Cette ressource est disponible en anglais.
  • Perte de mémoire et démence

    Patient.co.uk
    La démence entraîne une perte de capacité mentale, des changements d'humeur et des difficultés à mener les activités quotidiennes. Les facteurs de risque de maladie cardiaque pourraient augmenter votre risque de démence, comme le tabagisme, l'hypercholestérolémie, la consommation d'alcool ou le surpoids. Cette ressource est disponible en anglais.
AVERTISSEMENT Ces résumés sont fournis à titre informatif seulement. Ils ne peuvent pas remplacer les conseils de votre propre professionnel de la santé. Les résumés peuvent être reproduits à des fins éducatives sans but lucratif. Toute autre utilisation doit être approuvée par le Portail du vieillissement optimal de McMaster (info@mcmasteroptimalaging.org).

Voulez-vous savoir ce que lisent les professionnels? Inscrivez-vous pour accéder gratuitement à tous les contenus professionnels.

S'inscrire